about
Zerumbone induced apoptosis in liver cancer cells via modulation of Bax/Bcl-2 ratioFluid and diuretic therapy for preventing cisplatin-induced nephrotoxicityFluid and diuretic therapy for preventing cisplatin-induced nephrotoxicityXanthorrhizol: a review of its pharmacological activities and anticancer propertiesMechanisms of Cisplatin nephrotoxicityPersistence of cisplatin-induced DNA interstrand crosslinking in peripheral blood mononuclear cells from elderly and young individualsLiquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC/ESI-MS/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen/Deuterium (H/D) Exchange StudyProtective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in ratsAnticancer Chemotherapy and it's Anaesthetic Implications (Current Concepts)Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacyGap junction enhancer increases efficacy of cisplatin to attenuate mammary tumor growthLoss of α(E)-catenin potentiates cisplatin-induced nephrotoxicity via increasing apoptosis in renal tubular epithelial cellsRationally engineered polymeric cisplatin nanoparticles for improved antitumor efficacyMitochondria-Localized Fluorescent BODIPY-Platinum Conjugate.In-depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach.Quantitative imaging of platinum based on laser ablation-inductively coupled plasma-mass spectrometry to investigate toxic side effects of cisplatin.Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study.Plasma erythropoietin concentrations in patients receiving intensive platinum or nonplatinum chemotherapyRationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacyCholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicityAdvanced hepatocellular carcinoma with hepatic vein tumor thrombosis and renal dysfunction after hepatic arterial infusion chemotherapy effectively treated by liver resection with active veno-venous bypass: report of a case.A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity.Acute and cumulative effects of carboplatin on renal function.The kidney in oncology.Measuring protein excretion in pregnancy.Long-Term Renal Outcomes after Cisplatin Treatment.Randomized, multicenter, phase III trial of heptaplatin 1-hour infusion and 5-fluorouracil combination chemotherapy comparing with cisplatin and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer.The small-molecule TNF-α inhibitor, UTL-5g, delays deaths and increases survival rates for mice treated with high doses of cisplatin.Cisplatin: a review of toxicities and therapeutic applications.Toxicogenomics and cross-species biomarker discovery: applications in drug discovery and safety assessment.Current strategies to reduce cisplatin toxicity.Klotho as a potential biomarker and therapy for acute kidney injury.The nephrotoxic potential of drugs and chemicals. Pharmacological basis and clinical relevance.Changes in blood concentrations of trace metals in cancer patients receiving cisplatin-based chemotherapy.Cisplatin nephrotoxicity: a review of the literature.Effect of cationic side-chains on intracellular delivery and cytotoxicity of pH sensitive polymer-doxorubicin nanocarriers.Delivery of active DACH-Pt anticancer species by biodegradable amphiphilic polymers using thiol-ene radical addition.The effect of heavy metal chelators on the renal accumulation of platinum after cis-dichlorodiammineplatinum II administration to the rat.Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1.Renal epithelial gene expression profile and bismuth-induced resistance against cisplatin nephrotoxicity.
P2860
Q21245931-0F0FAB30-3C23-412B-80EC-0C1B2F64272BQ24236119-01BD0BFF-1847-4A76-977F-9F1763A3955FQ24242032-FDD64B95-B09D-429B-ACB4-2A4BB18A2508Q26779343-8F529578-E410-4019-B4D4-788DC309A4DEQ26996320-32D7868E-C581-4F85-A9E7-BC0862FE68BAQ28305738-4926B526-CD8A-4318-8E6A-3F5D07C563CFQ28547006-6AD80EC4-91EA-49D7-9DB5-B7104C23D0A7Q33805488-AD3455D2-EC53-4127-8085-4CA3A79D8A80Q33974943-81784FAD-7FE6-477C-AE40-59A3B91BBC83Q34005179-16C09A2A-BD14-4290-856E-5E033A957DC6Q34427761-1FCBE794-7052-4F23-B30F-9E09231C3C1AQ34737102-EC0258A6-887C-4631-8B7C-281694879043Q35173143-D458BA1E-A283-4433-8FFD-DDBEDDCF1CE4Q35559785-B7BC4D9F-110B-46A0-8E32-E2AC1A50EFFFQ35722244-5203DE46-4EE2-4F79-87ED-380E52F5FC12Q35811787-401605EC-904F-4992-BEF0-7414501738EAQ35837903-74D1DC50-7614-4B2E-9909-B0B2717BAD50Q36053949-E8ABEA85-9D53-442C-9644-E5FB964C156DQ36070256-70BBB475-B8B0-4FB5-BE19-2CE2B3F324F3Q36094353-FCBB2F9B-0C86-4A91-B722-6412591A6E65Q36120874-65668278-269A-47E5-A49E-8B985E1649E6Q36355684-FC8094FA-C180-44EB-B2B8-848B3DBCA2E8Q36468062-211DBE86-567D-4292-8CF6-7D232AC4C1F0Q36900332-28F7893E-4520-4557-BE2C-5E954041C156Q36930911-2E4F2D7A-B6D8-40F7-8C02-4C985EBABB73Q37069974-F7DD5724-4DFA-4CCB-830C-5B0E9BE00B92Q37234210-6F928CA5-43DE-43A5-A625-B630F3D542FEQ37259938-71ECC432-990F-4895-98BA-1A08EDF3EFBDQ37380106-B9831218-3846-48C3-9D33-A017029D3B55Q37658719-24DE3765-1D42-4919-B26A-109916C5D9C8Q37919774-E5CBC767-2576-49E3-9EAB-3B374115EC12Q38016065-EB0F93E3-DBC2-49D4-9971-8E64B89FC452Q38620778-A7085706-769E-4DB6-922B-C1AFE92D69DCQ39011030-F1D7B5C0-9DA2-4BDB-8330-63B7162E55D0Q39223600-2319E451-6935-4F7B-B1C5-66C026A3FB80Q39264651-B1E5A26B-7605-40D9-926A-1A7EA17719A5Q39418410-E626E902-9608-45C2-93E2-B9512799BB4EQ39929512-FD229FC1-2260-48EA-8684-AA3A38212381Q40357676-A7CB0819-0F40-4CE7-B11A-89AB3C8E345BQ40610540-D1CC17F7-A627-41DB-9407-B692662AE8C5
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Platinum nephrotoxicity.
@en
Platinum nephrotoxicity.
@nl
type
label
Platinum nephrotoxicity.
@en
Platinum nephrotoxicity.
@nl
prefLabel
Platinum nephrotoxicity.
@en
Platinum nephrotoxicity.
@nl
P1476
Platinum nephrotoxicity.
@en
P2093
Harrington JT
P304
P356
10.1016/0002-9343(78)90825-2
P407
P577
1978-08-01T00:00:00Z